Unterehmen auf Watchlist setzen
Travelers
ISIN: US89417E1091
WKN: A0MLX4
Curious about what AI knows about Travelers? Just one click more
More AI Integrations
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Travelers · ISIN: US89417E1091 · Business Wire (ID: 20250310771853)
11 März 2025 02:08PM

Travelers Offers New Product Liability Insurance for Life Sciences Companies


The Travelers Companies, Inc. (NYSE: TRV) today introduced Travelers Synergy℠, a new customizable product liability coverage tailored to life sciences companies. The offering will help medical technology, pharmaceutical, biopharmaceutical and digital health companies with the costs of product-related claims.

“Life sciences companies are dedicated to improving health care through innovation, and having liability coverage that addresses their individual needs can give them the confidence to create new solutions and bring them to market,” said Jennifer Ampulski, Life Sciences Practice Lead at Travelers. “Travelers Synergy provides a menu of insurance options that protect against issues arising from the product at any point in its development life cycle, from research to distribution.”

In addition to coverage for losses due to product- or work-related bodily injury or property damage, Travelers Synergy offers add-on coverages, including:

  • Errors and omissions liability coverage – Protects against financial loss caused by errors, omissions or negligent acts in connection with the company’s products or work.
  • Product recall expenses coverage – Provides reimbursement for certain product recall expenses directly attributable to a Class I recall of medical or biotechnology products.
  • Clinical trial medical expenses coverage – Provides payment for medical expenses for bodily injury occurring during a clinical trial, regardless of fault.

Customers will have access to Travelers’ industry-leading resources and support, including the Life Sciences Business Torts Claim team, a group of experienced Claim professionals who understand the intricacies of products liability and complex business disputes; specialized safety professionals; interactive risk management tools; and training services.

Travelers has been insuring life sciences businesses for more than 40 years, covering a range of specialties, including manufacturers of brand name and generic drugs, biologics, biosimilars, pediatric drugs, cell and gene therapy solutions, and veterinary pharmaceuticals and nutraceuticals.

Travelers Synergy will be available in most states for policies effective on or after April 1, 2025. To learn more about Travelers Synergy, contact your insurance agent or broker, or visit Travelers.com.

About Travelers

The Travelers Companies, Inc. (NYSE: TRV) is a leading provider of property casualty insurance for auto, home and business. A component of the Dow Jones Industrial Average, Travelers has more than 30,000 employees and generated revenues of more than $46 billion in 2024. For more information, visit Travelers.com.

Contact

Media:
Kate Thermansen, 860-954-1789
ktherman@travelers.com

Visuelle Wertentwicklung / Kursverlauf · Travelers
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
MIC: XNYS
This publication was provided by our content partner Business Wire
BusinessWire
via BusinessWire - Newsfeed
BusinessWire ©2025
BusinessWire
Kontakt:
101 California Street, 20th Floor San Francisco, CA, 94111 United States
+1.415.986.4422